Login

Kuvera interviews Rahul Singh, Chief Investment Officer - Equities at Tata Asset Management, about Multi Cap Funds.|Gaurav Rastogi is the CEO of Kuvera 00:10:00

Share On Facebook Share On Twitter

Gaurav Rastogi is the CEO of Kuvera

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Maria Shares Her Passion for Portland and Vision for Community Involvement | Maria Pope, CEO , Portland General Electric PLC.
00:10:00
Bursa's First Listing: Chin Hin Group's Confidence | Chiau Haw Choon - CEO of Chin Hin Group Berhad.
00:10:00
Central Asia Metals: Overview of Operations and Recent Acquisitions
00:10:00
GRAHAM DOWNS PRESIDENT AND CHIEF EXECUTIVE OFFICER, DIRECTOR of Cascadia Minerals Ltd
00:10:00
Tim Levy, Managing Director of Family Zone Cyber Safety Ltd introduces Proactive Investors to the company's innovative cyber security solutions.
00:10:00
New Cement Grinding Center Boosts Development in Northern Morocco | Mohamed Chafiq - CEO of Ciments du Maroc.
00:10:00
This venture capitalist chooses start-ups for investments|Oren Zeev,Founding Partner,Zeev Ventures
00:10:00
The executive officer of NetScout Systems Inc. emphasizes that organizations need to reassess their data sources for effective decision-making.
00:10:00
Izzy Englander is the founder and fund manager of Millennium Management, which currently manages $57.5 billion.
00:10:00
Ackermans & van Haaren Achieves Record Profit in 2019: €394.9M | Jan Suykens, CEO of Ackermans & van Haaren
00:10:00
Market Outlook: Tech Valuations, M&A Trends, and Investment Strategies
00:10:00
Basler AG invites customers and partners to share their #yourVISIONmoment, fostering engagement and collaboration through shared experiences.

© 2017 - Neuhu+